US88025U1097 - TXG - A2PPQJ (XNAS)
10X GENOMICS INC Action
14,11 USD
Cours actuels de 10X GENOMICS INC
Bourse | Ticker | Devise | Dernier échange | Cours | Variation journalière | Variation journalière % |
---|---|---|---|---|---|---|
NASDAQ |
TXG
|
USD
|
23.12.2024 13:14
|
14,11 USD
| 14,04 USD | 0,50 % |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
-2,50 % | -4,47 % | -1,40 % | -37,79 % | -28,16 % | -75,06 % | -80,89 % |
Company Profile for 10X GENOMICS INC Share
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Invested Funds
The following funds have invested in: 10X GENOMICS INC invested:
Fund | Vol. in million 26,43 | Percentage (%) 0,20 % |
Fund | Vol. in million 632,22 | Percentage (%) 0,17 % |
Fund | Vol. in million 61,33 | Percentage (%) 0,06 % |
Fund | Vol. in million 1,60 | Percentage (%) 0,06 % |
Fund | Vol. in million 929,27 | Percentage (%) 0,06 % |
Company Data for 10X GENOMICS INC Share
Name 10X GENOMICS INC
Company 10x Genomics, Inc.
Symbol TXG
Website https://www.10xgenomics.com
Primary Exchange
NASDAQ
WKN A2PPQJ
ISIN US88025U1097
Asset Class Share
Sector Healthcare
Industry Medical - Healthcare Information Services
CEO Dr. Serge Saxonov Ph.D.
Market Capitalization 3 Mrd.
Country United States of America
Currency USD
Employees 1,3 T
Address 6230 Stoneridge Mall Road, 94588-3260 Pleasanton
IPO Date 2019-09-12
Stock Splits
Date | Split |
---|---|
17.07.2006 | 1:2 |
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | 1KJ.F |
NASDAQ | TXG |
More Shares
Investors who 10X GENOMICS INC hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.